(19)
(11) EP 1 135 373 A1

(12)

(43) Date of publication:
26.09.2001 Bulletin 2001/39

(21) Application number: 99962727.6

(22) Date of filing: 10.11.1999
(51) International Patent Classification (IPC)7C07D 221/10, A61K 31/473, A61P 35/00
(86) International application number:
PCT/US9926/488
(87) International publication number:
WO 0034/246 (15.06.2000 Gazette 2000/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 07.12.1998 US 110558 P

(71) Applicant: ELI LILLY AND COMPANY
Indianapolis, Indiana 46285 (US)

(72) Inventors:
  • HAEHL, Kevin,Lee
    Caldy, (Wirral) CH48 2LD (GB)
  • PARKER, Bruce, Edward
    Zionsville, IN 46077 (US)
  • SHAW, David, Bryan
    Indianapolis, IN 46239 (US)
  • SIROIS, Paul, James
    Indianapolis, IN 46236 (US)
  • VARGAS, Ovidio
    Carmel, IN 46033 (US)
  • WEIGEL, Leland, Otto
    Indianapolis, IN 46254 (US)

(74) Representative: Burnside, Ivan John et al
Eli Lilly and Company LimitedLilly Research CentreErl Wood Manor
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) CRYSTALLINE FORM OF AN OCTAHYDRO-BENZO(F)QUINOLIN-3-ONE DERIVATIVE